Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients
Open Access
- 24 February 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
Abstract
Increased innate immune activation and inflammation are common findings in psychotic and affective (mood) disorders such as schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD), including increased numbers and activation of monocytes and macrophages. These findings often differ depending on the disorder, for example, we previously found increases in circulating inflammatory cytokines associated with monocytes and macrophages in SCZ, while BD had increases in anti-inflammatory cytokines. Despite these differences, few studies have specifically compared immune dysfunction in affective versus non-affective psychotic disorders and none have compared functional monocyte responses across these disorders. To address this, we recruited 25 first episode psychosis (FEP) patients and 23 healthy controls (HC). FEP patients were further grouped based on the presence (AFF) or absence (NON) of mood disorder. We isolated peripheral blood mononuclear cells and cultured them for 1 week with M-CSF to obtain monocyte-derived macrophages. These cells were then stimulated for 24 h to skew them to inflammatory and alternative phenotypes, in order to identify differences in these responses. Following stimulation with LPS and LPS plus IFN gamma, we found that macrophages from the NON-group had diminished inflammatory responses compared to both HC and AFF groups. Interestingly, when skewing macrophages to an alternative phenotype using LPS plus IL-4, the AFF macrophages increased production of inflammatory cytokines. Receiver operating curve analysis showed predictive power of inflammatory cytokine concentrations after LPS stimulation in the AFF group versus NON-group. Our results suggest dysfunctional monocyte responses in both affective and non-affective psychotic disorder, with varying types of immune dysfunction depending on the presence or absence of a mood component.This publication has 67 references indexed in Scilit:
- Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 StudyPopulation Health Metrics, 2012
- Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophreniaMolecular Psychiatry, 2012
- Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curvesCurrent Opinion in HIV and AIDS, 2010
- Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patientsInternational Journal of Neuropsychopharmacology, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- Depression: The Disorder and the BurdenIndian Journal of Psychological Medicine, 2010
- Neuroinflammation in Schizophrenia-Related Psychosis: A PET StudyJournal of Nuclear Medicine, 2009
- Cytokines and CNS DevelopmentNeuron, 2009
- Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patientsMolecular Psychiatry, 2009